Theranica (Series C)
Funding Details
Awarder
Inbox
Date Award
August 29, 2022
Vertical
Digital Therapeutics
Funding Amount
$45,000,000
Company Info
Traction
Recently surpassed a quarter of a million treatments administered to date.
Founders
Alon Ironi
Market
Idiopathic Pain Conditions
Location
Montclair, NJ, USA
Coinvestors
MoonCorundum Open Innovation, Lightspeed Venture Partners, LionBird, New Rhein Healthcare Investors, Takoa Invest
Company Description

Theranica is a prescribed digital therapeutics company dedicated to creating effective, safe, affordable, low-side effect therapies for idiopathic pain conditions. The company's award-winning flagship product, Nerivio®, is the first FDA-cleared smartphone-controlled prescribed wearable device for acute treatment of migraine.

Links